GlassScriptPhysician profile
Whitney C Hunter
NPI 1508146796
$10,401.68
in general payments reported to CMS, 2019-2025
46 companies · $1,681 in 2025
The $1,681 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $480 · 2022: $3,357 · 2023: $2,643 · 2024: $2,241 · 2025: $1,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,533 · Travel and Lodging: $31.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,533.10 |
| Travel and Lodging | $31.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,922.71 | 2021-2023 | Axonics |
| Medtronic, INC. | $1,478.71 | 2022-2025 | Interstim |
| Coloplast Corp | $1,102.57 | 2022-2025 | Speedicath |
| Janssen Biotech, INC. | $842.43 | 2021-2025 | Erleada, Akeega, Rybrevant |
| Abbvie INC. | $669.23 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $519.01 | 2021-2024 | Prolaris |
| Antares Pharma, INC. | $361.91 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $357.25 | 2023-2024 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $309.22 | 2022-2025 | Provenge |
| Merck Sharp & Dohme LLC | $273.86 | 2022-2025 | Lynparza, Keytruda |
| Endo Pharmaceuticals INC. | $229.07 | 2022-2024 | Xiaflex, Aveed |
| Baxter Healthcare | $194.87 | 2023-2025 | Floseal, Tisseel, Perclot |
| Myovant Sciences INC. | $191.40 | 2021-2022 | |
| Urogen Pharma, INC. | $143.16 | 2022-2025 | Jelmyto |
| Clarus Therapeutics INC. | $125.00 | 2021 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $124.99 | 2024 | Trodelvy |
| Novartis Pharmaceuticals Corporation | $119.36 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $117.90 | 2024 | Andexxa |
| Immunitybio, INC. | $112.32 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $94.02 | 2022-2025 | Pylarify |
| Blue Earth Diagnostics | $79.71 | 2021-2025 | Posluma |
| Intuitive Surgical, INC. | $79.00 | 2023 | Da Vinci Surgical System |
| Abc Home Medical Supply, INC. | $75.08 | 2022-2024 | |
| Procept Biorobotics Corporation | $74.93 | 2025 | |
| Avanos Medical | $71.56 | 2021 | |
| Olympus America INC. | $70.84 | 2024 | Itind System |
| Endo USA, INC. | $66.39 | 2024-2025 | Xiaflex, Aveed |
| Allergan, INC. | $65.56 | 2021-2022 | |
| Tolmar, INC. | $49.76 | 2023-2024 | |
| Astellas Pharma US INC | $46.39 | 2021 | |
| Convatec INC. | $42.49 | 2022 | |
| Halozyme INC | $42.04 | 2023 | |
| Accord Healthcare, INC. | $38.84 | 2023 | |
| Hollister Incorporated | $37.60 | 2022-2024 | Infyna Chic |
| Mission Pharmacal Company | $36.06 | 2022-2023 | Lithostat |
| Bayer Healthcare Pharmaceuticals INC. | $35.03 | 2022-2025 | |
| C. R. Bard, INC. & Subsidiaries | $33.99 | 2024 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $27.14 | 2021 | |
| Novo Nordisk INC | $23.46 | 2024 | |
| Photocure INC | $20.68 | 2024 | Cysview |
| Pfizer INC. | $19.54 | 2022 | |
| Urovant Sciences INC | $18.34 | 2022 | |
| Boston Scientific Corporation | $16.01 | 2022 | |
| Coopersurgical, INC. | $14.65 | 2025 | Ally II Ups |
| Telix Pharmaceuticals | $14.48 | 2024 | Illuccix |
| Lsi Solutions INC | $13.12 | 2024 | Jnw Urtrac, Ti-Knot, Running Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.